These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. COVID-19 in CVID: a Case Series of 17 Patients. Greenmyer JR; Joshi AY J Clin Immunol; 2022 Jan; 42(1):29-31. PubMed ID: 34669142 [No Abstract] [Full Text] [Related]
73. Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment. Ghandili S; Schönlein M; Lütgehetmann M; Schulze Zur Wiesch J; Becher H; Bokemeyer C; Sinn M; Weisel KC; Leypoldt LB Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359701 [TBL] [Abstract][Full Text] [Related]
74. Reduced SARS-CoV-2 infection and death after two doses of COVID-19 vaccines in a series of 1503 cancer patients. Heudel P; Favier B; Assaad S; Zrounba P; Blay JY Ann Oncol; 2021 Nov; 32(11):1443-1444. PubMed ID: 34333128 [No Abstract] [Full Text] [Related]
75. Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Benjamini O; Rokach L; Itchaki G; Braester A; Shvidel L; Goldschmidt N; Shapira S; Dally N; Avigdor A; Rahav G; Lustig Y; Ben David SS; Fineman R; Paz A; Bairey O; Polliack A; Levy I; Tadmor T Haematologica; 2022 Mar; 107(3):625-634. PubMed ID: 34320789 [TBL] [Abstract][Full Text] [Related]